Tiger Brokers

BRIEF-Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Reuters
08 Jan
BRIEF-<a href="https://laohu8.com/S/SLDB">Solid Biosciences</a> Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Jan 7 (Reuters) - Solid Biosciences Inc SLDB.O:

  • SOLID BIOSCIENCES ANNOUNCES FDA IND CLEARANCE FOR FIRST-IN-INDUSTRY DUAL ROUTE OF ADMINISTRATION GENE THERAPY TO TREAT BOTH NEUROLOGIC AND CARDIAC MANIFESTATIONS OF FRIEDREICH’S ATAXIA

  • SOLID BIOSCIENCES INC: PHASE 1B CLINICAL TRIAL INITIATION EXPECTED IN 2H 2025

Source text: ID:nGNXbQwqFD

Further company coverage: SLDB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10